Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers, Published online: 26 April 2018; doi:10.1038/s41416-018-0068-z

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers

https://ift.tt/2HSfu76